In order to elucidate the role of neutralizing IL-22 before onset of arthritis, anti-IL-22 antibody or isotype control was administered to mice from day 18 following immunization with collagen for a total of 8–10 days. The gene discussed is IL22; the disease is arthritic joint disease.